<html><body><h2>Case: 2557227</h2><h3> CDS Time: 1953-09-04</h3>
<patient name=2557227>
53.0 year old White_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">53</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Calcium</td><td width="200">8</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">118</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">2</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Potassium</td><td width="200">5</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Height</td><td width="200">62</td><td width="200">1953-8-23</td></tr>
<tr><td width="200">Chloride</td><td width="200">105.0</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">70</td><td width="200">1953-8-23</td></tr>
<tr><td width="200">BUN</td><td width="200">15</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">HGB</td><td width="200">14</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">HCT</td><td width="200">40</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Sodium</td><td width="200">138</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.1</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Weight</td><td width="200">155</td><td width="200">1953-8-23</td></tr>
<tr><td width="200">HbA1C</td><td width="200">6</td><td width="200">1953-8-24</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">6</td><td width="200">1953-8-24</td></tr>
<tr><td width="200">SGOT</td><td width="200">18</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Pulse</td><td width="200">78</td><td width="200">1953-8-23</td></tr>
<tr><td width="200">WBC</td><td width="200">9</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">110</td><td width="200">1953-8-23</td></tr>
<tr><td width="200">SGPT</td><td width="200">40</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1953-8-25</td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1953-8-29</td></tr>
<tr><td width="200">Renal_Insufficiency</td><td width="200"></td><td width="200">1953-8-29</td></tr>
<tr><td width="200">PLT</td><td width="200">Transfusion product order received.</td><td width="200">1953-8-31</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">Coronary_Artery_Disease</td><td width="200"></td><td width="200">1953-8-27</td></tr>
<tr><td width="200">CKD</td><td width="200"></td><td width="200">1953-8-25</td></tr>
</table>
<p><b>Medications:</b> aspirin(300.0) simvastatin(80.0) nitrate(60.0) Insulin(40.0) amiodarone(0.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of cononary artery disease]()</td></tr>
<tr><td width="200">On Amiodarone</td>
<td width="200"></td>
<td width="200"> Amiodarone[amiodarone]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(70/null) && Treatment_Systolic_BP(110/null) && presence of heart failure]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(70/null) && Treatment_Systolic_BP(110/null) && heart failure present]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[presence of CKD (icd9 codes)]()</td></tr>
<tr><td width="200">No med and K>=3.5</td>
<td width="200"></td>
<td width="200"> 1st line drug for hypertension[Potassium(4.7/1953-8-31) && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">drug intolerance ACE/ARB OR hypotension OR renal insufficiency</td>
<td width="200"></td>
<td width="200"> drug intolerance ACE/ARB OR hypotension OR renal insufficiency[presence of renal insufficiency ICD9]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1953-08-25</td>
<td width="200"> CKD()</td></tr>
<tr> <td width="200"></td>
<td width="200">1953-08-29</td>
<td width="200"> Renal_Insufficiency()</td></tr>
<tr> <td width="200"></td>
<td width="200">1953-08-29</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1953-08-25</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1953-08-27</td>
<td width="200"> Coronary_Artery_Disease()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1953-08-31</td>
<td width="200"> PLT()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
<p><b>Allergies and Adverse Reactions:</b> <ul>
<li>Substance: niacin Reaction: 
<li>Substance: furosemide Reaction: 
<li>Substance: bisoprolol Reaction: 
<li>Substance: niacin Reaction: 
<li>Substance: furosemide Reaction: 
<li>Substance: bisoprolol Reaction: 
 </ul>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 160 mg/dL(0-1 risk factors)
<p><b>Reached goal?</b> unknown(LDL_Cholesterol(no value))
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(70/null) && Treatment_Systolic_BP(110/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
<li>Diuretics and salt restriction are indicated if there is evidence of fluid retention. (Level of Evidence: C)
<li>Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

Diuretics and salt restriction are indicated if there is evidence of fluid retention. (Level of Evidence: C)
<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>aldosterone antagonist<ul><li>preference: neutral<li>No comment</ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker for stage C heart failure(Bisoprolol, Sustained release metoprolol succinate, Carvedilol)<ul><li>Adverse events:  (Beta_Blocker Stage C Heart Failure)  (Beta_Blocker Stage C Heart Failure) <li>preference: neutral</ul></ul><b>Considerations for adding drug: </b><ul><li>Ace_Inhibitor(Enalapril)<ul><li>preference: neutral<li>No comment</ul><li>ARB<ul><li>preference: neutral<li>No comment</ul><li>digoxin<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker stage B post MI(atenolol)<ul><li>preference: neutral<li>No comment</ul><li>Beta Blocker Stage B no MI<ul><li>Adverse events:  (Beta Blocker Stage B no MI)  (Beta Blocker Stage B no MI) <li>preference: neutral</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Heart_Failure) <li>preference: ruled out</ul></ul></body></html>